Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs. More than 200 startups are now competing to weave AI directly into research workflows, attracting growing interest…
Read More